fda semaglutide compound Compounded (GLP-1) Navigating Compounded Semaglutide: What Health

Golpour-Hamedani S, Bagherniy M, Khorvash F, Feizi A, Sharma M, Askari G

J Investig Dermatol 128:262269

Handling & storage For research use only

It is a major driver of type 2 diabetes (T2D), atherosclerotic cardiovascular disease (ASCVD), heart failure, chronic kidney disease (CKD), metabolic dysfunction-associated steatotic liver disease (MASLD), and a broad spectrum of mechanical and neurodevelopmental and neurobehavioral complications [1]

Gao Y, Kang K, Liu Y, Li N, Han Q, Liu H, Kong W, Zhang X, Huang R, Yang Z, Qi Z, Zheng J, Li M, Wang H, Li J, Liu R, Wang S, Zhang W, Zhao M, Yu K (2021) Mechanisms of renal-splenic axis involvement in acute kidney injury mediated by the 7nachr-nf-b signaling pathway